Racial/ethnic differences in the treatment of adolescent major depressive disorders (MDD) across healthcare providers participating in the medicaid program

Major Depressive Disorder (MDD) affects 7.5 –8.2% of adolescents every year (Cummings et al., 2011; Avenevoli et al., 2015). MDD is the third leading cause of death and has long-term negative impact on adolescents such as failure at school, substance abuse, and adult depression (NIH agency SAMHSA, 2008; Windfuhr et al., 2008; Hawton et  al., 2012; Emslie et al., 1997). Cognitive behavior therapy and interpersonal therapy are generally recommended for the treatment of mild depression (Hasler et al., 2005), and antidepressant medications are recommended for moderate to severe depression treatment along with behavioral therapies.
Source: Journal of Affective Disorders - Category: Neurology Authors: Tags: Research paper Source Type: research